Pancreatic Cancer Research

ResearcherCarl von Ossietzky Universität OldenburgActive in the last 2 years

N. Helge Meyer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1018-4942; OpenAlex author ID A5007503677. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 4

  1. Preoperative Anemia as a Prognostic Risk Factor for Inferior Oncological Survival Following Resection for Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/mpa.0000000000002448↗
  2. It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fimmu.2025.1495907↗
  3. Association Between Physical Activity and Pancreatic Cancer Risk and Mortality: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/cancers16213594↗
  4. Nanoparticle-based immunotherapy of pancreatic cancer. Last author DOI 10.3389/fmolb.2022.948898↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maximilian Bockhorn · 4 shared papers, 2022–2025 · strength 0.93
  2. Maarten W. Nijkamp · 3 shared papers, 2024–2025 · strength 0.75
  3. Gaetan Aime Noubissi Nzeteu · 2 shared papers, 2022–2025 · strength 0.47
  4. Mylena D. Bos · 2 shared papers, 2024–2025 · strength 0.47
  5. Christin Knickmeier · 1 shared paper, 2025 · strength 0.28
  6. Joost M. Klaase · 1 shared paper, 2025 · strength 0.24
  7. Allard G Wijma · 1 shared paper, 2025 · strength 0.24
  8. Joost M. Klaase · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.